Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 29, 2009

View Archived Issues

NIAID awards Cleveland BioLabs grant for protectan CBLB-502 research

Novel mPGES-1 inhibitors identified by NovaSAID for RA and other conditions

Perlegen Sciences launches BrevaGen breast cancer risk stratification test

FDA grants approval to Cepheid to market Xpert HemosIL FII and FV test

Abbott to acquire Solvay for EUR 4.5 billion in cash

Centocor's Stelara approved by the FDA for moderate to severe plaque psoriasis

Galapagos expands drug discovery collaboration with Schering-Plough

FDA grants priority review to sNDA of Cephalon's Nuvigil for jet lag disorder

Medivation initiates phase III MDV-3100 trial in advanced prostate cancer

BioLineRx reports final results from EAGLE trial in schizophrenia

Campath meets primary endpoint in phase III combination therapy trial for CLL

Chelsea Therapeutics reports preliminary phase III data of droxidopa for orthostatic hypotension

Keryx reports results of open-label extension study of Zerenex for hyperphosphatemia

Ticagrelor reduces cardiovascular death and heart attacks in patients with ACS

CHMP issues positive opinion for Yondelis in combination with Caelyx in ovarian cancer

Anti-RANKL antibody reduces breast cancer metastasis to bone in novel mouse model

Blocking RANK-L activity with ALX-0141, a potential treatment for bone resorption disorders

Phase II clinical benefit of everolimus in patients with recurrent endometrial carcinoma

New antimycobacterial calpinactam discovered at Kitasato University

Natural product AS-2077715 active against Trichophyton spp.

Icotinib hydrochloride safe and active in NSCLC patients in phase I/IIa trial

Boehringer Ingelheim presents MCH-R1 receptor antagonists for treating obesity

Opioid receptor antagonists for the treatment of pain presented by Alkermes

Novel compounds for the treatmemt of HCV infection claimed by Bristol-Myers Squibb

Stockholders from Raptor Pharmaceuticals and TorreyPines Therapeutics approve merger

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...